• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米医学在先进癌症免疫疗法中的应用。

Nanomedicine for advanced cancer immunotherapy.

机构信息

Institute of Quantum Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea; Department of Biophysics, Sungkyunkwan University, Suwon 16419, Republic of Korea; Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Department of Immunology, School of Medicine, Sungkyunkwan University, Suwon 16419, Republic of Korea.

出版信息

J Control Release. 2022 Nov;351:1017-1037. doi: 10.1016/j.jconrel.2022.10.004. Epub 2022 Oct 19.

DOI:10.1016/j.jconrel.2022.10.004
PMID:36220487
Abstract

Immunotherapy has emerged as a powerful strategy for liquid tumors to overcome the limitations of conventional cancer therapies. The nanomedical delivery system offers the possibility of enhancing cancer immunotherapy and expanding it to solid tumors. Here, we discuss the applications of medical nanoparticles to improve the efficacy of immunotherapy. We first focus on nanomedical particles used in cancer immunotherapy to deliver peptide and mRNA vaccines to the lymph nodes; and the exosome-based therapeutic cancer vaccine. Next, we highlight the applications of nanomedicine in immune checkpoint therapy to prolong the therapeutic effects, enhance tumor-targeting ability, and overcome drug resistance. We also evaluate the roles of nanomedical particles in oncolytic viral treatment, enabling the systemic injection of viruses or oncolytic plasmids/oncotoxic proteins; and virus entry in a receptor-independency manner. Lastly, we focus on nanoparticles in chimeric antigen receptor (CAR) T cell therapy to engineer CAR T cells, enhancing T cell proliferation and infiltration. We envision the nanomedical particles enhancing the therapeutic effects of immunotherapy and revolutionizing cancer therapy in the foreseeable future.

摘要

免疫疗法已成为克服传统癌症疗法局限性的有效策略,用于治疗液体肿瘤。纳米医学输送系统为增强癌症免疫疗法并将其扩展到实体瘤提供了可能。在这里,我们讨论了应用医疗纳米颗粒来提高免疫疗法的疗效。我们首先关注用于癌症免疫疗法的纳米医学颗粒,将肽和 mRNA 疫苗递送到淋巴结;以及基于外泌体的治疗性癌症疫苗。接下来,我们重点介绍了纳米医学在免疫检查点治疗中的应用,以延长治疗效果、增强肿瘤靶向能力和克服耐药性。我们还评估了纳米医学颗粒在溶瘤病毒治疗中的作用,使病毒或溶瘤质粒/细胞毒性蛋白能够全身注射;并以受体非依赖性的方式进入病毒。最后,我们关注嵌合抗原受体 (CAR) T 细胞疗法中的纳米颗粒,以工程化 CAR T 细胞,增强 T 细胞的增殖和浸润。我们设想纳米医学颗粒能够增强免疫疗法的治疗效果,并在可预见的未来彻底改变癌症治疗。

相似文献

1
Nanomedicine for advanced cancer immunotherapy.纳米医学在先进癌症免疫疗法中的应用。
J Control Release. 2022 Nov;351:1017-1037. doi: 10.1016/j.jconrel.2022.10.004. Epub 2022 Oct 19.
2
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.溶瘤病毒联合癌症免疫治疗:开创新一代癌症治疗。
Front Immunol. 2020 Apr 28;11:683. doi: 10.3389/fimmu.2020.00683. eCollection 2020.
3
The viral approach to breast cancer immunotherapy.病毒方法在乳腺癌免疫治疗中的应用。
J Cell Physiol. 2019 Feb;234(2):1257-1267. doi: 10.1002/jcp.27150. Epub 2018 Aug 26.
4
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.使用溶瘤病毒将嵌合抗原受体(CAR)靶点递送至实体瘤的有效联合免疫疗法。
Sci Transl Med. 2020 Sep 2;12(559). doi: 10.1126/scitranslmed.aaz1863.
5
Current and future immunotherapeutic approaches in pancreatic cancer treatment.当前和未来在胰腺癌治疗中的免疫治疗方法。
J Hematol Oncol. 2024 Jun 4;17(1):40. doi: 10.1186/s13045-024-01561-6.
6
Going viral with cancer immunotherapy.癌症免疫疗法的爆红。
Nat Rev Cancer. 2014 Aug;14(8):559-67. doi: 10.1038/nrc3770. Epub 2014 Jul 3.
7
CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge.嵌合抗原受体 T 细胞与溶瘤病毒:联合攻克实体瘤挑战。
Front Immunol. 2018 Oct 23;9:2460. doi: 10.3389/fimmu.2018.02460. eCollection 2018.
8
Virus-inspired strategies for cancer therapy.病毒启发的癌症治疗策略。
Semin Cancer Biol. 2022 Nov;86(Pt 3):1143-1157. doi: 10.1016/j.semcancer.2021.06.021. Epub 2021 Jun 26.
9
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.晚期胃癌免疫治疗的最新进展及未来展望。
Front Immunol. 2022 Jul 1;13:948647. doi: 10.3389/fimmu.2022.948647. eCollection 2022.
10
Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment.溶瘤病毒与细胞疗法联合用于实体瘤治疗。
Front Immunol. 2018 Sep 21;9:2103. doi: 10.3389/fimmu.2018.02103. eCollection 2018.

引用本文的文献

1
CAR-T cell therapy in brain malignancies: obstacles in the face of cellular trafficking and persistence.嵌合抗原受体T细胞疗法在脑恶性肿瘤中的应用:细胞转运与存活面临的障碍
Front Immunol. 2025 Jun 19;16:1596499. doi: 10.3389/fimmu.2025.1596499. eCollection 2025.
2
Triple role of exosomes in lung transplantation.外泌体在肺移植中的三重作用。
Front Immunol. 2025 Apr 11;16:1544960. doi: 10.3389/fimmu.2025.1544960. eCollection 2025.
3
Recent Advances in Polysaccharide-Based Hydrogels for Tumor Immunotherapy.用于肿瘤免疫治疗的多糖基水凝胶的最新进展
Gels. 2025 Feb 20;11(3):152. doi: 10.3390/gels11030152.
4
Potential and development of cellular vesicle vaccines in cancer immunotherapy.细胞囊泡疫苗在癌症免疫治疗中的潜力与发展
Discov Oncol. 2025 Jan 15;16(1):48. doi: 10.1007/s12672-025-01781-3.
5
Application of nanomedicines in tumor immunotherapy.纳米药物在肿瘤免疫治疗中的应用。
J Mol Cell Biol. 2025 Jun 12;16(12). doi: 10.1093/jmcb/mjae055.
6
Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach.探索细胞外囊泡与嵌合抗原受体(CAR)技术融合作为一种新型免疫治疗方法的潜力。
J Extracell Biol. 2024 Sep 26;3(9):e70011. doi: 10.1002/jex2.70011. eCollection 2024 Sep.
7
Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy.用于癌症免疫治疗中精确靶向药物递送和增强治疗效果的工程纳米颗粒。
Acta Pharm Sin B. 2024 Aug;14(8):3432-3456. doi: 10.1016/j.apsb.2024.05.010. Epub 2024 May 13.
8
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment.外泌体靶向 HBV-宿主相互作用重塑肝脏免疫微环境。
J Nanobiotechnology. 2024 Jun 5;22(1):315. doi: 10.1186/s12951-024-02544-y.
9
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update.默克尔细胞癌疫苗的当前进展:叙述性综述与更新
Vaccines (Basel). 2024 May 13;12(5):533. doi: 10.3390/vaccines12050533.
10
Targeting the chromatin structural changes of antitumor immunity.针对抗肿瘤免疫的染色质结构变化
J Pharm Anal. 2024 Apr;14(4):100905. doi: 10.1016/j.jpha.2023.11.012. Epub 2023 Nov 29.